Hepatitis B surface antigen and anti-hepatitis C antibodies among blood donors in the Islamic Republic of Iran
AbstractWe determined the prevalence rate of hepatitis B surface antigen [HBsAg] and anti-hepatitis C virus antibodies [anti-HCV] among 7897 healthy voluntary blood donors in Shiraz, Islamic Republic of Iran. Sera were examined for HBsAg and anti-HCV antibodies using a second-generation enzyme-linked immunosorbent assay. Positive sera for HBsAg were found in 85 [1.07%] of the individuals and anti-HCV antibodies were found in 47 [0.59%]. We compared our results with those of other studies and conclude that the prevalence rate of HBsAg in our area has decreased in the last 2 decades; from being an area of high prevalence, it is now one with moderate-to-low prevalence. Since there are few reports on the seroepidemiology of hepatitis C in the Islamic Republic of Iran, we could not assess the changes in prevalence of hepatitis C
Ghavanini, A.A. & Sabri, M.R. (2000). Hepatitis B surface antigen and anti-hepatitis C antibodies among blood donors in the Islamic Republic of Iran. http://www.who.int/iris/handle/10665/118976
EMHJ - Eastern Mediterranean Health Journal, 6 (5-6), 1114-1116, 2000
MetadataShow full item record
Showing items related by title and MeSH subject.
A collaborative study of the proposed international reference preparation for hepatitis B vaccine containing plasma-derived hepatitis B surface antigen (HBsAg / by Morag Ferguson, Valerie Seagroat and Geoffrey C. Schild Ferguson, Morag; Seagroatt, Valerie; Schild, Geoffrey Christopher; World Health Organization. Biologicals Unit (WHO/BS/86.1525, Rev.1. Unpublished, 1986)
Prevalence of hepatitis B surface antigen and hepatitis C virus antibodies among blood donors in Alexandria, Egypt Wasfi, O.A.S.; Sadek, N.A. (2011)Hepatitis B and C virus infections are common serious complications of blood transfusion. Over a 6-month period in 2007/08 all samples from a blood bank in Alexandria, Egypt [n=3420] were tested for hepatitis B surface antigen [HBsAg] and anti-hepatitis C virus [HCV] antibodies. A total of 119 donors [3.5%] were positive for anti-HCV and 47 [1.4%] for HBsAg. The mean age of HCV - positive donors was significantly higher than HBV-positive donors: 35.7 [SD 83] versus 29.9 [SD 7.4] years, HCV and HBV prevalence was highest among males [93.3% and ...
Hepatitis B surface antigen, hepatitis C and HIV antibodies in a low-risk blood donor group, Nigeria Egah, D.Z.; Banwat, E.B.; Audu, E.S.; Iya, D.; Mandong, B.M.; Anele, A.A.; Gomwalk, N.E. (2007)We investigated the seroprevalence of human immunodeficiency virus [HIV], hepatitis B virus [HBV] and hepatitis C virus [HCV] infection among 258 clergymen-in-training [age range 18-39 years] who represented a donor population that fulfilled the criteria for safe blood transfusion. In all, 15.1% of the men were positive for HBsAg, 4.3% were positive for anti-HCV and 2.7% were HIV- positive; 22.1% were infected with at least one of these viruses. Co-infection with HIV and HBV was found in 0.4% of the subjects, HBV and HCV in 0.4%, and HIV and HCV ...